Literature DB >> 28503075

Imprint cytology versus frozen section analysis for intraoperative assessment of sentinel lymph node in breast cancer.

Thalia Petropoulou1, Antonia Kapoula2, Aikaterini Mastoraki3, Aikaterini Politi2, Eleni Spanidou-Karvouni2, Ioannis Psychogios1, Ioannis Vassiliou1, Nikolaos Arkadopoulos3.   

Abstract

INTRODUCTION: Sentinel lymph node (SLN) biopsy is the gold standard for surgical staging of the axilla in breast cancer (BC). Frozen section (FS) remains the most popular means of intraoperative SLN diagnosis. Imprint cytology (IC) has also been suggested as a less expensive and equally accurate alternative to FS. The aim of our study was to perform a direct comparison between IC and FS on the same SLNs of BC cases operated in a single center by the same surgical team.
MATERIALS AND METHODS: Into this prospective study we enrolled 60 consecutive patients with histologically proven T1-T3 BC and clinically negative axilla. Sentinel nodes were detected using a standard protocol. The SLN(s) was always assessed by IC as well as FS analysis and immunohistochemistry. Nevertheless, all intraoperative decisions were based on FS analysis.
RESULTS: During the study period 60 patients with invasive BC were registered, with 80 SLNs harvested. Mean number of SLN(s) identified for each patient was 1.33. The sensitivity and specificity were 90% and 100%, respectively, for IC, and 80% and 100% for FS. Relevant positive/negative predictive values were 100%/98% for IC and 100%/96.15%, respectively, for FS. Overall accuracy was 98% for IC and 97% for FS. Therefore, statistically significant difference between the two methods in the detection of positive nodes was not elucidated (p=1.000).
CONCLUSIONS: IC appeared to be marginally more sensitive than FS in detecting SLN metastatic activity. Overall accuracy was 98.75%. With regard to the primary lesion characteristics, we conclude that initial lesion size and lymphovascular invasion play a pivotal role in metastatic involvement of the SLN with the dimensions of metastasis bearing no correlation with tumor size. Therefore, IC appears to be a sensitive and accurate method for the intraoperative assessment of SLN in BC patients, but further studies are required to confirm this interesting data.

Entities:  

Keywords:  breast cancer; frozen section; imprint cytology; sentinel lymph node biopsy

Year:  2017        PMID: 28503075      PMCID: PMC5426473          DOI: 10.2147/BCTT.S130987

Source DB:  PubMed          Journal:  Breast Cancer (Dove Med Press)        ISSN: 1179-1314


Introduction

Sentinel lymph node (SLN) biopsy is the gold standard for surgical staging of the axilla in breast cancer (BC).1,2 Intraoperative pathologic assessment of SLNs is desirable, because it may spare the patient a second operation if a preoperative decision has been made to proceed with completion axillary lymph node dissection (ALND) in case of positive SLN(s).3–6 Frozen section (FS) remains the most popular means of intraoperative SLN diagnosis in many centers although the overall rate of intraoperative SLN pathologic assessment appears to be declining, probably as an aftermath of the American College of Surgeons Oncology Group Z0011 Trial.7 The use of FS is accompanied with many drawbacks such as considerable waiting time, tissue loss, and cost. Furthermore, false-negative rates are always a concern.8 Intraoperative imprint cytology (IC) has also been suggested as a less expensive and equally accurate alternative to FS; this technique can also be performed on lymph nodes replaced by fat.9,10 Nevertheless, a higher probability of false-negative results has been recorded and the presence of micrometastasis cannot be excluded.11–13 Sensitivity also depends on the histologic type of the tumor, with lower rates of detection for lobular carcinoma (LC) in comparison with the more common ductal type.14,15 Additional immunohistochemical staining may aid in the detection of micrometastases even in LC and contributes to the increase of IC sensitivity.16 The aim of our study is to perform a direct, head-to head comparison between IC and FS on the SLNs of BC cases operated in a single center by the same surgical team in order to determine which method should be adopted as our standard method of intraoperative SLN evaluation in our academic unit.

Materials and methods

Patient selection criteria

Into this prospective study we enrolled 60 consecutive patients with histologically proven T1–T3 BC and clinically negative axilla who were admitted by a single surgical team to the Breast Unit of our university hospital from January 01, 2011, to December 31, 2013. The Institutional Review Board of Aretaieion University Hospital approved the study according to National and European legal standards. Furthermore, written informed consent was obtained by all the participants. In each patient SLN biopsy prior to ALND was implemented. Exclusion criteria were T4 tumors and/or clinically positive axilla, pregnancy, or lactation.

SLN biopsy protocol

Sentinel nodes were detected using a standard protocol of localization using radiopharmaceutical and blue dye injection intraoperatively, as previously described.17 Briefly the technique includes subcutaneous administration of 20–40 MBq of Nanocoll into the periareolar region within 2 hours prior to surgery. After induction of anesthesia an additional 2 mL of patent blue was injected in the periareolar area. Subsequently, the axilla was systematically scanned visually with a handheld gamma probe providing three-dimensional orientation about the precise location of the SLN. Preoperative lymphoscintigraphy was performed in 60% of cases. Surgical criteria for SLN(s) include the identification of all “hot” and blue nodes as previously described (Figure 1).18 The SLN(s) was always assessed by IC as well as FS analysis and IHC. During SLN assessment in the laboratory the patient was submitted to the scheduled definitive operation for BC such as wide local excision or mastectomy with or without reconstruction. In case of macrometastatic disease in the SLN(s) the patient underwent the standard ALND. According to the design of the survey all intraoperative decisions were based on FS analysis, which has been the standard of care in our surgical department for many years.
Figure 1

Identification of “hot” and blue nodes in a surgical specimen of sentinel lymph node biopsy.

Intraoperative IC

The SLN(s) were received fresh in the department of pathology. SLN(s) greater than 5 mm in size were sliced to sections of 2-mm thickness, whereas SLN(s) less than 5 mm were bisected. Two slides of touch imprints were provided from each section of the SLN and were air-dried. The first one was stained with the Wright–Giemsa method (Hemacolor rapid staining, Merck KGaA, Darmstadt, Germany) and assessed immediately by an experienced cytopathologist. The other one was fixed in cold acetone for 30 sec, allowed to dry, and rinsed in phosphate buffer saline.

Intraoperative FS and IHC

In all cases two sections were cut in the cryostat and subsequently stained with hematoxylin and eosin (H&E) for FS analysis and assessed by another dedicated cytopathologist. The rest of the tissue as well as the FS blocks were embedded in paraffin. From each block, three slides were obtained and additional two or three sections were stained with H&E. The results of both IC and FS examination of the SLN(s) were communicated to the surgical team as soon as they were available, during the ongoing surgical procedure. If the cytomorphology was not diagnostic a rapid immunohistochemical analysis was performed in the second slide using the Dako REAL Envision detection system (DAKO, Glostrup, Denmark) and cytokeratin AE1/AE3 as the primary antibody. After completion of the intraoperative assessment, the lymph node sections were fixed in 10% neutral buffered formalin overnight, followed by paraffin embedding of the entire specimen and routine postoperative histopathological evaluation.

Statistical analysis

Variables were investigated for normality of distributions using the Kolmogorov–Smirnov test. Comparisons of numeric data between the two groups were performed with the independent unpaired t-test with regard to mean size of the primary tumor or metastatic foci. Mann–Whitney statistical analysis was employed in case of violation of normality. Comparisons of categorical data were carried out by the method of chi-square or Fisher’s exact test, as appropriate. Pairwise multiple comparisons were established with McNemar’s test. All analyses were executed using SPSS version 13.0, and p<0.05 was indicated as the statistically significant level.

Results

During the study period, 60 patients with invasive BC were registered, with 80 SLNs harvested. Average age was 61.3 years (range 31–82). Mean number of SLN(s) identified for each patient was 1.33. Mean tumor size was significantly larger (2.34±1.53 cm) in patients with axillary metastatic disease in comparison with SLN-negative women (1.58±0.68 cm; p=0.016). Meticulous postoperative histological examination revealed 10 positive and 50 negative cases (Figure 1). False-positive results were not reported. Among SLN-positive patients we detected six ductal adenocarcinomas, one LC, and three cases of mixed ductal/lobular type with seven macrometastases and two micrometastases elucidated. One case of isolated tumor cells in an SLN was detected. The sensitivity and specificity was 90% and 100%, respectively, for IC and 80% and 100% for FS. Relevant positive/negative predictive values were 100%/98% for IC and 100%/96.15%, respectively, for FS. Overall accuracy was 98% for IC and 97% for FS. Therefore, we found no statistically significant difference between the two methods in the detection of positive nodes (p=1.000). Furthermore, comparison of FS analysis with the combination of IC and IHC provided similar evidence (p=0.5). Additionally, the overall accuracy in detecting macrometastases was 100% for IC and 97.5% for FS with relevant sensitivity rates 100% and 89%, respectively. False-positive results were absent. Moreover, a statistically significant correlation has been suggested between FS and IHC (p<0.001), FS and IC (p<0.001) and IHC and the combined IC+IHC technique (p<0.001) with regard to the time required to the completion of the histological examination. Results are summarized in Table 1.
Table 1

Tumors’ characteristics in invasive breast cancer patients submitted to sentinel lymph node biopsy

PatientsN=60
SLNs80
SLN/Patient1.33
Mean age61.3
Mean tumor size in SLN (+) patients2.34±1.53 cm
Mean tumor size in SLN (−) patients1.58±0.68 cm
Positive cases10
Negative cases50

Abbreviation: SLN, sentinel lymph node.

Study participants included 10 premenopausal and 50 postmenopausal women. No statistically significant difference was found between the ratio of premenopausal and postmenopausal state in women with positive SLN (20% versus 16%, p=0.668). Furthermore, 42 patients were defined as T1 tumors, 16 women were characterized as T2 lesions, and two patients appeared with T3/T4 tumors. Additional statistical analysis identified that T stage was correlated significantly to metastatic involvement of SLN (p=0.016). In addition, the size of metastases on the SLN(s) bore no correlation with the T stage of the primary tumor (p=0.977). On the other hand, there is a trend for positive correlation between the percentage of positive SLNs and the extent of metastatic disease (r2=0.362, p=0.086) as well as the tumor size (r2=0.464, p=0.043) (Figure 2). Indications of extranodal extension of nodal metastasis were not apparent.
Figure 2

Correlation between the percentage of positive sentinel lymph nodes and tumor size in 60 breast cancer patients.

Among the 60 patients of this study, estrogen receptors (ER) positivity was apparent in 53 cases and progesterone receptors (PgRs) positivity in 43 samples. Moreover, all patients with positive SLN (n=10) were ER positive. Nevertheless, the percentage of positive ERs and PgRs was not significantly different between women with axillary involvement versus those with negative SLN biopsy (p=0.589 and p=0.709, respectively).

Discussion

Imprint or touch-preparation cytology of SLNs has been established in the literature as an effective modality with high specificity and a wide range of sensitivity rates. In accordance with a recent meta-analysis including 31 methodologically acceptable surveys, the pooled sensitivity of IC was 63% with specificity levels as high as 99%. Associated pooled sensitivity for macrometastases detection was 81% and that for micrometastases determination only 22%. Mean or median primary tumor size, the prevalence of metastases, and the proportion of micrometastatic evidence proved significant determinants of the outcome in single-variable meta-regression analysis.5 Moreover, the proportion of micrometastases appeared the only significant risk factor in multivariable examination. Finally, frozen sectioning had better sensitivity compared to IC in three among four direct comparative evaluations.19 IC is a simple, rapid, and cost-effective technique for axillary assessment, which also preserves the SLN for further histological examination. Interpretation by an experienced cytopathologist is always required.20,21 Therefore, IC is operator dependent as reflected in the wide range of success in the published reports. On the other hand, FS has been described as the method of choice for intraoperative evaluation of the nodal status of the axilla for decades. Nevertheless, despite its reliability, FS analysis is a time-consuming technique as well as labor intensive and expensive. Our results depicting sensitivity and specificity rates of 90% and 100%, respectively, are comparable with previously published data for FS and IC.22–25 When IC is combined with IHC, the sensitivity and specificity are 100%. Even though IHC is a very sensitive and accurate method, additional cost and time required exclude it as a routine diagnostic procedure. Nevertheless, in case of questionable diagnosis or morphologic uncertainty with regard to potential detection of atypical cells implying the presence of micrometastases or istiocytes, an immunohistochemical examination is often warranted.26 Increasing the number of serial sections has been suggested to improve sensitivity. Recently, intraoperative ultrarapid IHC has been investigated for its feasibility, validity, and effectiveness in comparison with FS. Ultrarapid cytokeratin IHC significantly enhanced intraoperative detection of metastasis in SLNs without increased time for assessment (Table 2). This technique is currently not widely available and requires specialized expertise. Other experimental techniques such as intraoperative multiparameter flow cytometry and real-time polymerase chain reaction for cytokeratins in SLNs have also yielded promising results.27,28
Table 2

Comparison of imprint cytology, frozen sectioning, and immunohistochemistry analysis in invasive breast cancer patients submitted to sentinel lymph node biopsy

Number of patientsImprint cytology
Frozen sectioning
Immunohistochemistry
SensitivitySpecificitySensitivitySpecificitySensitivitySpecificity
Nagashima et al31124629979100N/AN/A
Sauer et al3321451987599N/AN/A
Leidenius et al3237568998399N/AN/A
Beach et al37326910054100N/AN/A
Celebioglu et al2210051N/A73.5N/A75.5N/A
Safai et al649901009010090100
Francz et al23N/A69.497.868.598.968.598.9
Upender et al104091.710095.8100100100
Mori et al2518347.188.288.298.3N/AN/A
Lumachi et al2412670.391.975.7100N/AN/A
Krishnamurthy et al9100501007297.578100
Our study609010080100100100

Abbreviation: N/A, not available.

LC presents a low-grade cytomorphology similar to lymphoid cellular structure. Therefore, acute identification of axillary metastatic disease on both IC and definite postoperative histology remains problematic. Additional thick eosinophilic background and hyperplasia of small cells lacking adhesion is an important determinant for the presence of false-negative results.29 Therefore, in case of LC, intraoperative FS has been considered superior to IC. It is also essential to mention that in strong suspicion of LC based on previously preceded fine-needle aspiration (FNA) in the initial lesion, rapid analysis with either IC or FS should be always accompanied by IHC as associated cellular morphological characteristics remain controversial even in permanent stains. Evaluation of the FNA of the SLN section by the same cytopathologist dedicated to the diagnostic approach of the initial lesion remains an important parameter for the result accuracy. Another specific disadvantage of FS is that in case of a small-sized SLN the possibility of tissue destruction with parallel absence of material for final histological examination is apparent. Therefore, FS cannot be performed on occasion because of inadequate safety of protecting the permanent specimen.30–33 Moreover, LC cells are morphologically similar to lymphoid cells, thus making identification of metastases more challenging on both IC and definitive postoperative histology.34 In our survey, statistical analysis could not be performed among LC-affected patients, and further association with false-negative results has not been reported because of the small number of recorded cases. Recently described intraoperative molecular methods for the detection of metastatic BC to SLN detect mRNA expression of the epithelial marker cytokeratin 19 (CK19). CK19 is normally absent in the lymph node, and its high level of expression is encountered in the majority of BC cells. The number of copies of mRNA for CK19 can be assessed with the one-step nucleic acid amplification test (OSNA). Sensitivity and specificity of the OSNA modification for the detection of metastases have been elucidated in a few surveys using different research protocols. The disadvantage of the OSNA method is homogenization of SLN and the associated lack of further possibility of histological evaluation.35 Thus, the same sample cannot be analyzed by both molecular OSNA analysis and subsequent postoperative histological examination. In addition, due to different parts of SLN used for analysis in each of the two methods, inconsistent results have been referred between the OSNA test and final biopsy. Relevant cost is also high in comparison with FS and IC alternative techniques. In conclusion, IC appeared to be marginally more sensitive than FS in detecting SLN metastatic activity. In our prospective study, we did not face the problem reported in the literature, regarding the detection of micrometastases and ITCs. Overall accuracy was 98.75%. Diagnostic management was considered controversial in four cases presented with extensive sinus histiocytosis of the SLN and minimal reaction with cytokeratin AE1/AE3 and one case of LC atypical micrometastasis. With regard to the primary tumor characteristics, we conclude that initial lesion size and lymphovascular invasion play a pivotal role in metastatic involvement of the ASLN with the dimensions of metastasis bearing no correlation with tumor size. Furthermore, IC may be strongly indicated also in case of extranodal extension, in which a macrometastasis is almost always associated with the invasion of adjacent soft tissue. This morphological feature is very important in SLN of BC patients, also for the prognostic point of view.36 False-positive results that could lead to unnecessary ALND are very rare. The sensitivity of 90% of our research compares favorably with other reported studies of IC and FS.12,22,23 Therefore, IC is definitely an easy, quick, sensitive, and accurate method for the intraoperative assessment of SLN in BC patients.
  37 in total

Review 1.  Current controversies concerning sentinel lymph node biopsy for breast cancer.

Authors:  Masakuni Noguchi
Journal:  Breast Cancer Res Treat       Date:  2004-04       Impact factor: 4.872

2.  Intraoperative evaluation of sentinel lymph nodes in breast cancer: comparison of frozen sections, imprint cytology and immunocytochemistry.

Authors:  M Francz; K Egervari; Z Szollosi
Journal:  Cytopathology       Date:  2010-10-26       Impact factor: 2.073

Review 3.  Detection of the sentinel lymph node in breast cancer.

Authors:  Santosh K Somasundaram; Dennis W Chicken; Mohammed R S Keshtgar
Journal:  Br Med Bull       Date:  2008-01-03       Impact factor: 4.291

4.  Sentinel node imaging in breast cancer using superficial injections: technical details and observations.

Authors:  S K Somasundaram; D W Chicken; W A Waddington; J Bomanji; P J Ell; M R S Keshtgar
Journal:  Eur J Surg Oncol       Date:  2009-06-21       Impact factor: 4.424

5.  Decline in Frozen Section Diagnosis for Axillary Sentinel Lymph Nodes as a Result of the American College of Surgeons Oncology Group Z0011 Trial.

Authors:  Julie Anne Bishop; Jihong Sun; Nicolas Ajkay; Mary Ann G Sanders
Journal:  Arch Pathol Lab Med       Date:  2015-12-30       Impact factor: 5.534

6.  Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?

Authors:  Jacqueline S Jeruss; Kelly K Hunt; Yan Xing; Savitri Krishnamurthy; Funda Meric-Bernstam; Scott B Cantor; Merrick I Ross; Janice N Cormier
Journal:  Cancer       Date:  2006-11-15       Impact factor: 6.860

7.  Intraoperative evaluation of sentinel lymph nodes in breast carcinoma by imprint cytology, frozen section and rapid immunohistochemistry.

Authors:  Sharma Upender; Harsh Mohan; Uma Handa; Ashok K Attri
Journal:  Diagn Cytopathol       Date:  2009-12       Impact factor: 1.582

8.  Rapid intraoperative immunohistochemical evaluation of sentinel lymph nodes for metastatic breast carcinoma.

Authors:  Elizabeth I Johnston; Robyn A Beach; Sandra M Waldrop; Diane Lawson; Cynthia Cohen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2006-03

9.  Accuracy of imprint cytology for intraoperative diagnosis of sentinel node metastases in breast cancer.

Authors:  Kazuyoshi Motomura; Sachiko Nagumo; Yoshifumi Komoike; Hiroki Koyama; Hideo Inaji
Journal:  Ann Surg       Date:  2008-05       Impact factor: 12.969

10.  Serial sectioning of sentinel nodes in patients with breast cancer: a pilot study.

Authors:  I Jannink; M Fan; S Nagy; G Rayudu; K Dowlatshahi
Journal:  Ann Surg Oncol       Date:  1998-06       Impact factor: 5.344

View more
  5 in total

Review 1.  Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation.

Authors:  Madeline T Olson; Quan P Ly; Aaron M Mohs
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

Review 2.  Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer.

Authors:  Matthias Holzlechner; Eliseo Eugenin; Brendan Prideaux
Journal:  Cancer Rep (Hoboken)       Date:  2019-12

3.  Cytologic smears improve accuracy of frozen sections of ovarian tumors in the community practice settings.

Authors:  Adela Cimic; Maria Mironova; Fady Khoury-Collado; Ziyan Salih
Journal:  Cytojournal       Date:  2019-05-24       Impact factor: 2.091

4.  Intraoperative Sentinel Lymph Node Imprint Cytology Diagnosis in Breast Cancer Patients by General Surgical Pathologists: A Single-Institution Experience of 4327 Cases.

Authors:  Yi-Chin Chang; Chi-Yuan Tzen
Journal:  J Cytol       Date:  2022-02-17       Impact factor: 1.000

5.  Evaluation of intraoperative touch imprint cytology on axillary sentinel lymph nodes in invasive breast carcinomas, a retrospective study of 1227 patients comparing sensitivity in the different tumor subtypes.

Authors:  Hafsteinn Ingi Pétursson; Anikó Kovács; Jan Mattsson; Roger Olofsson Bagge
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.